Skip to content
★ Sign in to follow
TO

Tristan Orpin

Executive
Total declarations
267
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (117 ops.)
€23.7M

Latest filing published 08 Nov 2016 for Illumina, INC., €86k.

Filing timeline

BuySale
Tristan Orpin

First 200 filings with a declared amount

Insider track record

Disclosed buys
0
Disclosed sells
117
Signal history

Tristan Orpin: trading record in brief

Tristan Orpin appears in our data through filings on Illumina, Inc. shares, published by SEC (Form 4). The record holds 267 filings, for trades running from 11 September 2006 to 7 November 2016.

Sales make up the whole of the open-market record (117 sales, €23.7M). The rest of the record consists of 29 share grants and 120 option exercises.

The newest entry dates from 8 November 2016: a share grant of €86k, in Illumina, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Tristan Orpin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations260 total
  • ◆
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    95,545 USD11SEC
    697 shares@ US$137.083.1% of flowCommon StockSEC:0001127602-16-066465:0
  • ◆
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    103,045 USD11SEC
    685 shares@ US$150.433.3% of flowCommon StockSEC:0001127602-16-045844:0
  • ◇
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    0SEC
    24,000 shares0Common StockSEC:0001127602-16-045355:0
  • ◆
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    0SEC
    12,000 shares0Common StockSEC:0001127602-16-045355:1
  • ◆
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    3M USD19SEC
    18,156 shares@ US$157.4593.6% of flowCommon StockSEC:0001127602-16-045355:2
  • ◆
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    0SEC
    529 sharesCommon StockSEC:0001127602-16-038844:0
  • ◆
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    0SEC
    265 sharesCommon StockSEC:0001127602-16-038844:1
  • ◆
    EVP Clinical GenomicsExecutivesIllumina, Inc.
    0SEC
    3,164 shares0Common StockSEC:0001127602-15-033992:0
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    189,676 USD0SEC
    6,667 shares@ US$28.45Common StockSEC:0001110803-13-000260:0
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    494,625 USD0SEC
    6,667 shares@ US$74.19Common StockSEC:0001110803-13-000260:1
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    995,750 USD0SEC
    35,000 shares@ US$28.45Common StockSEC:0001110803-13-000246:0
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    3M USD0SEC
    35,000 shares@ US$71.98Common StockSEC:0001110803-13-000246:1
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    948,324 USD0SEC
    33,333 shares@ US$28.45Common StockSEC:0001110803-13-000240:0
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    2M USD0SEC
    33,333 shares@ US$66.55Common StockSEC:0001110803-13-000240:1
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    17,487 USD0SEC
    1,667 shares@ US$10.49Common StockSEC:0001110803-13-000240:2
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    110,939 USD0SEC
    1,667 shares@ US$66.55Common StockSEC:0001110803-13-000240:3
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    253,847 USD0SEC
    12,667 shares@ US$20.04Common StockSEC:0001110803-13-000240:4
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    842,989 USD0SEC
    12,667 shares@ US$66.55Common StockSEC:0001110803-13-000240:5
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    400,800 USD0SEC
    20,000 shares@ US$20.04Common StockSEC:0001110803-13-000194:0
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    1M USD0SEC
    20,000 shares@ US$70.00Common StockSEC:0001110803-13-000194:1
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    100,200 USD0SEC
    5,000 shares@ US$20.04Common StockSEC:0001110803-13-000194:2
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    340,000 USD0SEC
    5,000 shares@ US$68.00Common StockSEC:0001110803-13-000194:3
  • ◇
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    100,200 USD0SEC
    5,000 shares@ US$20.04Common StockSEC:0001110803-13-000189:0
  • ▼
    Sr VP & Chief Commercial OfficExecutivesIllumina, Inc.
    328,400 USD0SEC
    5,000 shares@ US$65.68Common StockSEC:0001110803-13-000189:1
  • ◇
    SVP & Chief Commercial OfficerExecutivesIllumina, Inc.
    100,200 USD0SEC
    5,000 shares@ US$20.04Common StockSEC:0001110803-13-000184:0

25 of 260 declarations